Published in Nature on April 17, 2011
Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 4.31
Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet (2013) 2.67
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat Immunol (2013) 2.60
HIV and HLA class I: an evolving relationship. Immunity (2012) 1.91
Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet (2013) 1.75
Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol (2013) 1.74
Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice. Blood (2015) 1.41
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions. Nucleic Acids Res (2014) 1.38
Interrogating the major histocompatibility complex with high-throughput genomics. Hum Mol Genet (2012) 1.35
Immunogenetics of spontaneous control of HIV. Annu Rev Med (2012) 1.34
Immunogenetics of HIV disease. Immunol Rev (2013) 1.25
A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics (2011) 1.25
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol (2012) 1.24
The T-cell response to HIV. Cold Spring Harb Perspect Med (2012) 1.20
High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism. J Immunol (2012) 1.16
The microRNA-148/152 family: multi-faceted players. Mol Cancer (2013) 1.14
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum Mol Genet (2012) 1.14
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet (2012) 1.10
MiRNA-mediated control of HLA-G expression and function. PLoS One (2012) 1.08
The emerging role of HLA-C in HIV-1 infection. Immunology (2011) 1.06
The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet (2011) 1.06
Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A (2013) 1.04
The immunogenetics of multiple sclerosis: A comprehensive review. J Autoimmun (2015) 1.04
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA. Mol Cell (2016) 1.03
HIV controllers: a multifactorial phenotype of spontaneous viral suppression. Clin Immunol (2011) 1.02
HIV control through a single nucleotide on the HLA-B locus. J Virol (2012) 1.00
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol (2015) 0.99
The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation. EMBO J (2012) 0.98
The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet (2012) 0.98
Disentangling human tolerance and resistance against HIV. PLoS Biol (2014) 0.97
MicroRNAs, immune cells and pregnancy. Cell Mol Immunol (2014) 0.97
Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics. Retrovirology (2012) 0.96
NK cells: immune cross-talk and therapeutic implications. Immunotherapy (2011) 0.96
Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity. J Leukoc Biol (2015) 0.96
Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet (2013) 0.96
Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J Immunol (2015) 0.95
Host genes important to HIV replication and evolution. Cold Spring Harb Perspect Med (2012) 0.95
Genomic modulators of the immune response. Trends Genet (2012) 0.94
Differential MHC class I expression in distinct leukocyte subsets. BMC Immunol (2011) 0.94
HIV-1 Vpu Mediates HLA-C Downregulation. Cell Host Microbe (2016) 0.93
Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells. Immunogenetics (2012) 0.92
Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res (2014) 0.92
Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol (2013) 0.91
Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population. PLoS One (2014) 0.89
Trophoblasts, invasion, and microRNA. Front Genet (2013) 0.88
High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging. BMC Genomics (2014) 0.87
Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics (2011) 0.87
HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation. Front Immunol (2014) 0.87
Translating the Untranslated Region. J Immunol (2015) 0.86
An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element. PLoS One (2013) 0.86
Identification and characterization of microRNAs in Baylisascaris schroederi of the giant panda. Parasit Vectors (2013) 0.85
The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection. J Leukoc Biol (2011) 0.85
Resolving the variable genome and epigenome in human disease. J Intern Med (2012) 0.85
OLFML3 expression is decreased during prenatal muscle development and regulated by microRNA-155 in pigs. Int J Biol Sci (2012) 0.85
Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity. PLoS One (2011) 0.85
Co-evolution of MHC class I and variable NK cell receptors in placental mammals. Immunol Rev (2015) 0.85
miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. PLoS One (2014) 0.85
HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues. Viruses (2012) 0.84
Roles of natural killer cells in antiviral immunity. Curr Opin Virol (2015) 0.83
HLA-C and HIV-1: friends or foes? Retrovirology (2012) 0.83
Prediction of altered 3'- UTR miRNA-binding sites from RNA-Seq data: the swine leukocyte antigen complex (SLA) as a model region. PLoS One (2012) 0.83
A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypes. Mol Immunol (2012) 0.82
The future potential for cocaine vaccines. Expert Opin Biol Ther (2014) 0.82
Post-transcriptional regulation of interferons and their signaling pathways. J Interferon Cytokine Res (2014) 0.82
Identification of nuclear-enriched miRNAs during mouse granulopoiesis. J Hematol Oncol (2014) 0.81
Immunogenetics: Genome-Wide Association of Non-Progressive HIV and Viral Load Control: HLA Genes and Beyond. Front Immunol (2013) 0.81
Genetic variability in markers of HLA-C expression in two diverse South African populations. PLoS One (2013) 0.81
HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy. Biosystems (2014) 0.80
Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach. J Biol Chem (2014) 0.80
Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. Front Immunol (2013) 0.80
Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo. PLoS One (2014) 0.80
Host genetic variation and HIV disease: from mapping to mechanism. Immunogenetics (2017) 0.79
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol (2016) 0.79
High-allelic variability in HLA-C mRNA expression: association with HLA-extended haplotypes. Genes Immun (2014) 0.79
HLA-G/C, miRNAs, and their role in HIV infection and replication. Biomed Res Int (2013) 0.79
Integrated host and viral transcriptome analyses reveal pathology and inflammatory response mechanisms to ALV-J injection in SPF chickens. Sci Rep (2017) 0.79
Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol (2016) 0.79
Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations. Sci Rep (2015) 0.78
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control. Sci Rep (2017) 0.77
Reconstructing the temporal progression of HIV-1 immune response pathways. Bioinformatics (2016) 0.77
A gene feature enumeration approach for describing HLA allele polymorphism. Hum Immunol (2015) 0.77
Epigenetic regulation of differential HLA-A allelic expression levels. Hum Mol Genet (2015) 0.77
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms. J Transl Med (2014) 0.77
Use of dried blood spots for the determination of genetic variation of interleukin-10, killer immunoglobulin-like receptor and HLA class I genes. Tissue Antigens (2011) 0.77
Reprogramming immune responses via microRNA modulation. Microrna Diagn Ther (2013) 0.77
What do all the (human) micro-RNAs do? BMC Genomics (2014) 0.76
Role of HLA Adaptation in HIV Evolution. Front Immunol (2016) 0.76
Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression. Front Immunol (2014) 0.76
SubmiRine: assessing variants in microRNA targets using clinical genomic data sets. Nucleic Acids Res (2015) 0.76
Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples. PLoS One (2016) 0.75
HLA polymorphism and risk of multiple myeloma. Leukemia (2016) 0.75
The roles of RNA processing in translating genotype to phenotype. Nat Rev Mol Cell Biol (2016) 0.75
Allorecognition of HLA-C Mismatches by CD8(+) T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities. Front Immunol (2016) 0.75
HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region. Am J Hum Genet (2016) 0.75
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.75
HLA-C -35kb expression SNP is associated with differential control of β-HPV infection in squamous cell carcinoma cases and controls. PLoS One (2014) 0.75
Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class Ia Molecules. PLoS One (2016) 0.75
Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes. Biol Blood Marrow Transplant (2016) 0.75
Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland. PLoS One (2015) 0.75
Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts. Hum Immunol (2012) 0.75
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science (2006) 18.14
Genome-wide associations of gene expression variation in humans. PLoS Genet (2005) 17.27
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A (2006) 10.11
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet (2007) 2.58
The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet (2006) 2.43
Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med (1986) 1.89
TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol (1998) 1.70
Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med (1995) 1.63
Molecular structure of human histocompatibility antigens: the HLA-C series. Eur J Immunol (1977) 1.61
Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.57
A critical look at HLA-G. Trends Immunol (2008) 1.55
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med (1992) 1.53
In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol (2009) 1.27
Position-dependent repression and promotion of DQB1 intron 3 splicing by GGGG motifs. J Immunol (2006) 1.11
A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages. J Immunol (2008) 1.06
Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes. Methods Mol Biol (2010) 0.86
Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2007) 25.52
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature (2009) 9.51
HIV preferentially infects HIV-specific CD4+ T cells. Nature (2002) 9.28
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science (2011) 9.00
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis (2003) 8.00
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
WGAViewer: software for genomic annotation of whole genome association studies. Genome Res (2008) 7.15
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA (2006) 7.14
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood (2004) 7.09
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med (2004) 6.33
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis (2009) 6.17
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03
Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol (2012) 4.91
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation (2004) 4.87
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67
Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol (2005) 4.61
Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science (2007) 4.60
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet (2010) 4.53
Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology (2008) 4.50
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol (2007) 4.41
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol (2006) 4.26
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med (2009) 4.22
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr (2010) 4.20
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med (2006) 4.19
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 4.14
Advantage of rare HLA supertype in HIV disease progression. Nat Med (2003) 4.08
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med (2010) 4.07
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog (2013) 4.05
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature (2010) 3.96
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis (2009) 3.91
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med (2004) 3.87
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem (2009) 3.71
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS (2006) 3.70
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med (2005) 3.68
Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol (2007) 3.61
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature (2010) 3.57
Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest (2003) 3.57
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet (2003) 3.57
Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature (2011) 3.56
Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother (2004) 3.48
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med (2003) 3.41
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog (2012) 3.35
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis (2003) 3.33
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet (2002) 3.32